Flow Traders U.S.’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Flow Traders U.S.'s XBI Position: Q1 2026 in Review
Flow Traders U.S. opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q1 2026: 60,268 shares worth $7.7M. The stake represents 0.24% of the portfolio and ranks #75 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in XBI as recently as Q2 2025.
Flow Traders U.S. first reported a position in XBI in Q2 2014 and has held it in 14 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Flow Traders U.S. held 60,268 shares of State Street SPDR S&P Biotech ETF worth $7.7M as of Q1 2026.
- State Street SPDR S&P Biotech ETF was a new Flow Traders U.S. position in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.24% of Flow Traders U.S.'s portfolio in Q1 2026, its #75 holding.
- Flow Traders U.S. first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 14 quarters since.
- 815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Flow Traders U.S.'s 13F filing for Q1 2026, filed 15 May 2026.